Metallophosphoesterase 1, a novel candidate gene in hepatocellular carcinoma malignancy and recurrence

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90. doi:10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Altekruse SF, McGlynn KA, Reichman ME. 2009. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491. doi:10.1200/JCO.2008.20.7753.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–390.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Ribes J, Borras J. 1999. Epidemiology of primary liver cancer. Semin Liver Dis. 19:271–285. doi:10.1055/s-2007-1007117.
   PubMed Web of Science ®Google Scholar
• Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. 2006. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 45:529–538. doi:10.1016/j.jhep.2006.05.013.
   PubMed Web of Science ®Google Scholar
• Galle PR, Tovoli F, Foerster F, Worns MA, Cucchetti A, Bolondi L. 2017. The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy. J Hepatol. 67:173–183. doi:10.1016/j.jhep.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Sapisochin G, Bruix J. 2017. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 14:203–217. doi:10.1038/nrgastro.2016.193.
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim MJ, Park YK, Im JY, Kwon SM, Kim HC, Woo HG, Wang HJ. 2017. Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype. Oncotarget. 8:22903–22916. doi:10.18632/oncotarget.14248.
   PubMedGoogle Scholar
• Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–346.
   PubMed Web of Science ®Google Scholar
• Aravalli RN, Cressman EN, Steer CJ. 2013. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol. 87:227–247. doi:10.1007/s00204-012-0931-2.
   PubMed Web of Science ®Google Scholar
• Nguyen DX, Bos PD, Massague J. 2009. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 9:274–284. doi:10.1038/nrc2622.
   PubMed Web of Science ®Google Scholar
• Lohoff FW, Ferraro TN, Brodkin ES, Weller AE, Bloch PJ. 2010. Association between polymorphisms in the metallophosphoesterase (MPPE1) gene and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 153B:830–836. doi:10.1002/ajmg.b.31042.
   PubMed Web of Science ®Google Scholar
• Vuoristo JT, Ala-Kokko L. cDNA cloning, genomic organization and expression of the novel human metallophosphoesterase gene MPPE1 on chromosome 18p11.2. Cytogenet Cell Genet. 2001;95:60–63.
   PubMedGoogle Scholar
• Fujita M, Maeda Y, Ra M, Yamaguchi Y, Taguchi R, Kinoshita T. 2009. GPI glycan remodeling by PGAP5 regulates transport of GPI-anchored proteins from the ER to the Golgi. Cell. 139:352–365. doi:10.1016/j.cell.2009.08.040.
   PubMed Web of Science ®Google Scholar
• Liu M, Jiang L, Guan XY. 2014. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell. 5:673–691. doi:10.1007/s13238-014-0065-9.
   PubMed Web of Science ®Google Scholar
• Lee JS. 2015. The mutational landscape of hepatocellular carcinoma. Clin Mol Hepatol. 21:220–229. doi:10.3350/cmh.2015.21.3.220.
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez N, Macher HC, Rubio A, Jimenez-Arriscado P, Bernal-Bellido C, Bellido-Diaz ML, Suarez-Artacho G, Guerrero JM, Gomez-Bravo MA, Molinero P. 2016. Detection of p53 mutations in circulating DNA of transplanted hepatocellular carcinoma patients as a biomarker of tumor recurrence. Adv Exp Med Biol. 924:25–28. doi:10.1007/978-3-319-42044-8_5.
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. 2007. Patterns of somatic mutation in human cancer genomes. Nature. 446:153–158. doi: 10.1038/nature05610.
   PubMed Web of Science ®Google Scholar
• Zhu X, Liu W, Qiu X, Wang Z, Tan C, Bei C, Qin L, Ren Y, Tan S. 2017. Single nucleotide polymorphisms in MLH1 predict poor prognosis of hepatocellular carcinoma in a Chinese population. Oncotarget. 8:80039–80049. doi:10.18632/oncotarget.16899.
   PubMedGoogle Scholar
• Liu B, Yu S. 2018. Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling. Biomed Pharmacother. 107:243–253. doi:10.1016/j.biopha.2018.07.177.
   PubMed Web of Science ®Google Scholar
• Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, et al. 2012. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 44:1117–1121. doi: 10.1038/ng.2391.
   PubMed Web of Science ®Google Scholar
• Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, et al. 2011. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 43:828–829. doi: 10.1038/ng.903.
   PubMed Web of Science ®Google Scholar
• Takai A, Dang HT, Wang XW. 2014. Identification of drivers from cancer genome diversity in hepatocellular carcinoma. Int J Mol Sci. 15:11142–11160. doi:10.3390/ijms150611142.
   PubMed Web of Science ®Google Scholar
• Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, et al. 2012. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 44:694–698. doi: 10.1038/ng.2256.
   PubMed Web of Science ®Google Scholar
• Sheen IS, Jeng KS, Wu JY. Is p53 gene mutation an indication of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol. 2003;9:1202–1207.
   PubMed Web of Science ®Google Scholar
• Panera N, Crudele A, Romito I, Gnani D, Alisi A. 2017. Focal adhesion kinase: insight into molecular roles and functions in hepatocellular carcinoma. Int J Mol Sci. 18:E99. doi:10.3390/ijms18010099.
   PubMed Web of Science ®Google Scholar
• Gross-Goupil M, Riou P, Emile JF, Saffroy R, Azoulay D, Lacherade I, Receveur A, Piatier-Tonneau D, Castaing D, Debuire B, et al. 2003. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation. Int J Cancer. 104:745–751. doi: 10.1002/ijc.11017.
   PubMed Web of Science ®Google Scholar
• Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. 2007. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 28:622–629. doi:10.1002/humu.20495.
   PubMed Web of Science ®Google Scholar
• Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. 2007. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 26:2166–2176. doi:10.1038/sj.onc.1210279.
   PubMed Web of Science ®Google Scholar
• Kew MC. 2011. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol. 26(Suppl 1):144–152. doi: 10.1111/j.1440-1746.2010.06546.x.
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–2079.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics (Oxford, England). 2010;25:1754–1760.
   Web of Science ®Google Scholar
• Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. 2012. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22:568–576. doi:10.1101/gr.129684.111.
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Hakonarson H. 2010. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38:e164. doi:10.1093/nar/gkq603.
   PubMed Web of Science ®Google Scholar
• Murphy KM, Berg KD, Eshleman JR. 2005. Sequencing of genomic DNA by combined amplification and cycle sequencing reaction. Clin Chem. 51:35–39. doi:10.1373/clinchem.2004.039164.
   PubMed Web of Science ®Google Scholar
• Zhang B, Kirov S, Snoddy J. 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33:W741–748. doi:10.1093/nar/gki475.
   PubMed Web of Science ®Google Scholar
• Kim BJ, Ryu SW, Song BJ. 2006. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem. 281:21256–21265. doi:10.1074/jbc.M510644200.
   PubMed Web of Science ®Google Scholar
• Zhan XH, Xu QY, Tian R, Yan H, Zhang M, Wu J, Wang W, He J. MicroRNA16 regulates glioma cell proliferation, apoptosis and invasion by targeting Wip1-ATM-p53 feedback loop. Oncotarget. 2017;8:54788–54798.
   PubMedGoogle Scholar